Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 18.01
+0.41 (2.33%)
Jul 20, 2026, 3:04 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 6.95 billion as of July 20, 2026. Its market cap has decreased by -23.26% in one year.
Market Cap
6.95B
Enterprise Value
5.72B
Revenue
1.19B
Ranking
n/a
PE Ratio
20.23
Stock Price
18.01
ChartMarket Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 6.95B, an increase of 335.07%. That is a compound annual growth rate of 17.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 6.95B | -12.23% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGI Genomics | 13.80B |
| Guangzhou Kingmed Diagnostics Group | 12.22B |
| Dian Diagnostics Group | 11.16B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.85B |
| Maccura Biotechnology Co.Ltd | 5.48B |
| SMO ClinPlus CO.,LTD. | 4.30B |
| Cowealth Medical China | 4.10B |